INFLUENZA B VIRUS - ANVISA Registration 80464810585
Access comprehensive regulatory information for INFLUENZA B VIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80464810585 and manufactured by NOVATEC IMMUNDIAGNOSTICA GMBH TECHNOLOGIE & WALDPARK. The registration is held by ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until Jul 16, 2028.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including R-BIOPHARM AG, NOVATEC IMMUNDIAGNOSTICA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
80464810585
25351237084201813
09377976000152
Company Information
Dates and Status
Jul 16, 2018
16/07/2028
09/18/2025 19:00:01
VÍRUS INFLUENZA B
Micropartículas Influenza B IgM CLIA
Not specified
80102513468
Jun 30, 2025
VÍRUS INFLUENZA B
Micropartículas Influenza B IgM CLIA
AUTOBIO DIAGNOSTICS CO., LTD
80102513468
Jun 30, 2025
VÍRUS INFLUENZA B
SERION ELISA classic Influenza B IgA
Not specified
81905510060
Nov 28, 2022
VÍRUS INFLUENZA B
SERION ELISA classic Influenza B IgA
INSTITUT VIRION\SERION GMBH
81905510060
Nov 28, 2022
VÍRUS INFLUENZA B
SERION ELISA classic Influenza B IgG
Not specified
81905510073
Nov 28, 2022

